The trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.

During his first term, Trump in 2020 had pushed a similar "most favored nation" rule for drug prices that would have applied to Medicare payments but was later rescinded by the Biden administration.

"Administration Releases Medicare Drug Price Negotiation Program Draft Guidance For 2028", Health Affairs Forefront, May 15, 2025 . DOI: 10.1377/forefront.20250515.568228 Caption. 1101 Connecticut ...

Trump initially tried to implement this policy in 2020 as part of a broader effort by his administration to cut U.S. drug costs, but it was halted by a federal judge following a lawsuit from the ...